Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

John B.A.G. Haanen, Franck Carbonnel, Caroline Robert et al. · Annals of Oncology · 2017 · 2.3K citations

Immunotoxicology, Immunodeficiencies, Immunology +6

Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens

Giuseppe Zamboni, Jutta L�ttges, Paola Capelli et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2004 · 664 citations

Pancreatic Cancer, Autoimmune Disease, Pancreatic Fluid Collection +11

Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury

Yoh Zen, Matthew M. Yeh · Modern Pathology · 2018 · 281 citations · Full text

Immunology, Pathology, Liver Biopsy +18

Immune‐related adverse reactions in the hepatobiliary system: second‐generation check‐point inhibitors highlight diverse histological changes

Yoh Zen, Yen‐Ying Chen, Yung‐Ming Jeng et al. · Histopathology · 2019 · 81 citations

Hepatobiliary and Pancreatic: Nivolumab‐related cholangiopathy

Coralie Hamoir, M. De Vos, F. Clinckart et al. · Journal of Gastroenterology and Hepatology · 2018 · 29 citations · Full text